Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Intelectin-1 is a secreted glycoprotein lectin encoded by the ITLN1 gene. Also known as omentin or intestinal lactoferrin receptor, it binds specifically to exocyclic vicinal diols found on microbial carbohydrates such as galactofuranose—structures present on bacteria but absent from mammalian tissues—thus playing an important role in innate immunity at mucosal surfaces like the intestine. It also acts as a receptor for lactoferrin, an iron-binding protein involved in antimicrobial defense. Intelectin-1 forms disulfide-linked homotrimers (~120 kDa) that are N-glycosylated and secreted mainly by goblet cells within the gut epithelium but also found in vascular tissue, omental fat, heart, colon, thymus, ovary/testis. Its expression increases during inflammatory conditions such as ulcerative colitis; it modulates host-microbe interactions by binding select commensal/pathogenic bacteria within mucus layers. Additionally recognized as an adipocytokine circulating in blood plasma/serum with roles proposed in metabolic regulation and cardiovascular protection following injury through inhibition of fibrosis/hypertrophy/smooth muscle proliferation/migration/calcification while promoting revascularization.
Not applicable for approved drugs. For experimental approaches: - Potential mechanisms include modulation of immune responses by binding to bacterial carbohydrates. - May influence inflammatory pathways via its lectin activity. - Modulation of metabolic processes as an adipocytokine.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Intelectin-1 (ITLN1).